Celltrion’s Truxima approved in Australia
-
Australia's Therapeutic Goods Administration has approved Celltrion's biosimilar Truxima, The Korea Herald reported Friday.
-
The therapy is a biosimilar of Roche's MabThera.
-
Additionally, the drug is Celltrion's second biosimilar to gain clearance in the country after Remsima.